IPO - Check IPO Date, Price, Lot Size

Gujarat Kidney & Super Speciality Ltd IPO

The Company is one of the regional healthcare companies located in the central region of state of Gujarat and operate a chain of midsized multispeciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. The Company, on a consolidated basis, operates seven (07) multispeciality hospitals and four (04) pharmacies operating within its Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand), Ashwini Medical Store (Anand) and Apex Multispeciality & Trauma Center (Bharuch) with a total bed capacity of 490 beds, approved bed capacity of 445 beds and operational bed capacity of 340 beds.

Gujarat Kidney & Super Speciality Ltd IPO Details

Total Shares Offered

₹ 2,20,00,000

Offer to Public

TBA

Retail Max (Shares)

₹ 22,00,000

Pre Issue Promoters Holding

₹ 5,63,33,900

Exchange

BSE

Issue size

₹ 250.8 Cr

IPO Open Date

Dec 22, 2025

Close Date

Dec 24, 2025

Lot Size

128

Min Investment

₹ 13,824

Issue Type

Book Building

Listing Date

Dec 30, 2025

Gujarat Kidney & Super Speciality Ltd IPO Dates

Dec 22, 2025

Opening date

Dec 24, 2025

Closing date

Dec 26, 2025

Basis of Allotment

Dec 29, 2025

Initiation of Refunds

Dec 29, 2025

Credit of Shares

Dec 30, 2025

Listing date

Details

Sector	Type
Sector	Healthcare
Sub Sector	NA
Issue Type	Book Building

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*	Shares Bid*
QIB	0.5x	16500000	8188928
NII	5.73x	3300000	18899840
Retail	19.04x	2200000	41879808
Employee	0x	0	0
Total	3.13x	22000000	68968576

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

0.5x

5.73x

19.04x

3.13x

16500000

3300000

2200000

22000000

8188928

18899840

41879808

68968576

Gujarat Kidney & Super Speciality Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	4.77	0.00	TBA
EBITDA	2.51	-0.01	TBA
PAT	1.45	-0.01	TBA
Total Assets	6.90	1.19	TBA
Share Capital	0.20	0.20	TBA
Total Borrowings	3.23	0.04	TBA
Operating Activities (Net Cash)	1.73	-0.01	TBA
Investing Activities (Net Cash)	0.00	0.01	TBA
Financing Activities (Net Cash)	3.23	0.04	TBA
Net Cashflow	1.18	0.00	TBA

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney And Super Speciality Limited (the Issuer or the Company) was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, in order to align its name with the business carried out by the Company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by its Board of Directors in their meeting held on September 04, 2023, and by its Shareholders in an extraordinary general meeting held on September 06, 2023, the name of the Company was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad. Further, the Company was converted into a public limited company pursuant to a resolution passed by its Board of Directors in their meeting held on November 02, 2023 and by its Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of the Company was changed to `Gujarat Kidney and Super Speciality Limited' and a fresh certificate of incorporation dated November 24, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.

As per the D&B Report, India has witnessed a notable increase in public spending on healthcare infrastructure, reflecting a growing commitment to bolstering the nation's healthcare system. Government health expenditure stood at approximately 1.9% of GDP in 2023-24, an increase from 1.28% in 2018-19. The government aims to raise this to 2.5% by 2025, as outlined in the National Health Policy. This upward trend indicates a prioritization of healthcare investment to address the evolving needs of the population. The public healthcare segment in India, while witnessing positive strides, continues to grapple with the demands of a vast and diverse population, necessitating sustained efforts and investments.

Peer Comparison:

Yatharth Hospital & Trauma Care Services Ltd
GPT Healthcare Ltd
KMC Speciality Hospitals (India) Ltd

Gujarat Kidney & Super Speciality Ltd Key Points

Strengths

Pre-eminence in renal sciences, with established sub-superspecialties in urology and strong capabilities in other specialties.

`Right-sized', full service and strategically located hospitals leading to high return on capital.

Ability to attract, train and retain quality medical professionals.

Investment in infrastructure, processes and clinical excellence driving affordability, and a strong value proposition for stakeholders.

Track record of operating and financial performance and growth.

Risk

The company proposes to use a portion of the Net Proceeds from the Issue for acquisition of Parekhs Hospital Private Limited, following which the Company will be responsible for overseeing and managing the Parekhs Hospital. Its may face difficulties in completing the acquisition within the terms mentioned in term sheet, affecting the company future plans and prospects.

The Company proposes to utilise a portion of the Net Proceeds from the Issue towards making part-payment of purchase consideration for the acquisition of Ashwini Medical Centre, pursuant to the Acquisition Agreement. In case of delay in raising funds from the Issue, its may face challenges in paying the consideration to sellers of Ashwini Medical Centre.

The company proposed plans with respect to funding the capital expenditure requirement for construction of new hospital are subject to the risk of unanticipated delays in obtaining approvals and implementation which may adversely affect its business and results of operations. Further, the company are yet to place orders for such capital expenditure requirements. There is no assurance that its would be able to source such capital expenditure requirements in a timely manner or at commercially acceptable prices, which could adversely affect the company expansion plans. Its may be unsuccessful in implementing the company growth plans of expansion in Gujarat, India in a timely manner or at all, which may have an adverse effect on its business, financial condition and results of operations. Furthermore, the proposed construction of the new hospital is planned to be carried out on leased land, which includes potential challenges or risks related to the terms of lease arrangement, could have adverse effect on the company business, financial position, and results of operations.

Strategy

Pursue strategic inorganic growth opportunities.

Implementation of initiatives to improve existing operational efficiencies.

Continue to recruit and retain skilled healthcare professionals.

Strengthen its existing hospitals and its offerings and add new capabilities and specialties.

How To Apply for Gujarat Kidney & Super Speciality Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Gujarat Kidney & Super Speciality Ltd IPO?

Gujarat Kidney & Super Speciality Ltd's IPO offers shares for up to 250.8 It begins on Dec 22, 2025 and ends on Dec 24, 2025.

What is the price of the Gujarat Kidney & Super Speciality Ltd IPO?

The price of Gujarat Kidney & Super Speciality Ltd IPO ranges between ₹108 to ₹114 per share.

What are the open and close dates for the Gujarat Kidney & Super Speciality Ltd IPO?

The Gujarat Kidney & Super Speciality Ltd IPO opens on Dec 22, 2025 and closes on Dec 24, 2025.

When will the Gujarat Kidney & Super Speciality Ltd IPO be allotted?

The allotment for the Gujarat Kidney & Super Speciality Ltd IPO will be finalised on Dec 26, 2025. The shares will be listed on BSE and NSE on Dec 30, 2025.

What is the minimum lot size required for Gujarat Kidney & Super Speciality Ltd IPO?

The minimum lot size for Gujarat Kidney & Super Speciality Ltd IPO is 128 shares, priced between ₹108 to ₹114 per share.

What is the GMP of Gujarat Kidney & Super Speciality Ltd IPO?

The GMP (Grey Market Premium) of Gujarat Kidney & Super Speciality Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Gujarat Kidney & Super Speciality Ltd IPO?

To check the allotment status of Gujarat Kidney & Super Speciality Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Gujarat Kidney & Super Speciality Ltd IPO getting listed?

The Gujarat Kidney & Super Speciality Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Dec 22, 2025, and closes on Dec 24, 2025. The allotment is finalised on Dec 26, 2025.

How do you apply for the Gujarat Kidney & Super Speciality Ltd IPO?

To apply for the Gujarat Kidney & Super Speciality Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.